These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27877096)

  • 1. A Prospective Pilot Study on the Systemic Absorption of Oral Vancomycin in Children With Colitis.
    Antoon JW; Hall M; Metropulos D; Steiner MJ; Jhaveri R; Lohr JA
    J Pediatr Pharmacol Ther; 2016; 21(5):426-431. PubMed ID: 27877096
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible red-man syndrome associated with systemic absorption of oral vancomycin in a child with normal renal function.
    Bergeron L; Boucher FD
    Ann Pharmacother; 1994 May; 28(5):581-4. PubMed ID: 8068993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant absorption of oral vancomycin in a patient with clostridium difficile colitis and normal renal function.
    Aradhyula S; Manian FA; Hafidh SA; Bhutto SS; Alpert MA
    South Med J; 2006 May; 99(5):518-20. PubMed ID: 16711316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Unusual Case of Ototoxicity with Use of Oral Vancomycin.
    Gomceli U; Vangala S; Zeana C; Kelly PJ; Singh M
    Case Rep Infect Dis; 2018; 2018():2980913. PubMed ID: 30057833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Absorption of Enteral Vancomycin in a Child with Clostridium difficile Colitis and Renal Impairment.
    Wood A; Wassil K; Edwards E
    J Pediatr Pharmacol Ther; 2013 Oct; 18(4):315-7. PubMed ID: 24719593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitis.
    Matzke GR; Halstenson CE; Olson PL; Collins AJ; Abraham PA
    Am J Kidney Dis; 1987 May; 9(5):422-5. PubMed ID: 3578270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum vancomycin concentrations after oral and intracolonic vancomycin administration in a patient with colonic discontinuity and severe
    Wilke K; Helbig S; de With K
    Am J Health Syst Pharm; 2018 May; 75(9):e189-e193. PubMed ID: 29691261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for systemic vancomycin exposure following administration of oral vancomycin for the treatment of Clostridium difficile infection.
    Pettit NN; DePestel DD; Fohl AL; Eyler R; Carver PL
    Pharmacotherapy; 2015 Feb; 35(2):119-26. PubMed ID: 25689243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rash induced by enteral vancomycin therapy in an older patient in a long-term care ventilator unit: case report and review of the literature.
    Barron J; Lattes A; Marcus EL
    Allergy Asthma Clin Immunol; 2018; 14():73. PubMed ID: 30450116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An extremely high bioavailability of orally administered vancomycin in a patient with severe colitis and renal insufficiency.
    Yamazaki S; Suzuki T; Suzuki T; Takatsuka H; Ishikawa M; Hattori N; Fujishiro T; Miyauchi H; Oami T; Ariyoshi N; Oda S; Matsubara H; Ishii I
    J Infect Chemother; 2017 Dec; 23(12):848-851. PubMed ID: 28923303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic absorption of oral vancomycin in patients with Clostridium difficile infection.
    Rao S; Kupfer Y; Pagala M; Chapnick E; Tessler S
    Scand J Infect Dis; 2011 May; 43(5):386-8. PubMed ID: 21198337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis.
    Chihara S; Shimizu R; Furukata S; Hoshino K
    Scand J Infect Dis; 2011 Feb; 43(2):149-50. PubMed ID: 20831355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity Reaction Following Administration of Low-Dose Oral Vancomycin for the Treatment of Clostridium difficile in a Patient With Normal Renal Function.
    Baumgartner LJ; Brown L; Geier C
    J Pharm Pract; 2017 Dec; 30(6):650-652. PubMed ID: 27630210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected serum level of vancomycin after oral administration in a patient with severe colitis and renal insufficiency.
    Yamazaki S; Nakamura H; Yamagata S; Miura G; Hattori N; Shinozaki K; Sadahiro T; Toyoda A; Nakasa H; Ariyoshi N; Oda S; Harigaya K; Kitada M
    Int J Clin Pharmacol Ther; 2009 Nov; 47(11):701-6. PubMed ID: 19840535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs.
    Le F; Arora V; Shah DN; Salazar M; Palmer HR; Garey KW
    Pharmacotherapy; 2012 Feb; 32(2):129-34. PubMed ID: 22392421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report.
    Turner D; Levine A; Kolho KL; Shaoul R; Ledder O
    J Crohns Colitis; 2014 Nov; 8(11):1464-70. PubMed ID: 24958064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
    Nelson RL; Suda KJ; Evans CT
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004610. PubMed ID: 28257555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red Man Syndrome Due to Oral Vancomycin in Chronic Kidney Disease Patients: A Case Report.
    Yadav S; Hashmi MU; Shah S; Sarwar A; Ibrahim R
    Cureus; 2022 Aug; 14(8):e28024. PubMed ID: 36134053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
    Lei DK; Ollech JE; Andersen M; Weisshof R; Zmeter N; Sossenheimer P; Rubin DT
    Am J Gastroenterol; 2019 Dec; 114(12):1904-1908. PubMed ID: 31714359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
    Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
    JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.